Top Markets
Coin of the day
PsyRX CNS Bio-Tech Ltd PsyRX CNS Bio-Tech Ltd

PsyRX CNS Bio-Tech Ltd

PSRX
Rank in Stocks #42513
PsyRX CNS Bio-Tech Ltd is dedicated to developing cannabinoid-based... PsyRX CNS Bio-Tech Ltd is dedicated to developing cannabinoid-based pharmaceuticals and healthcare products. Its portfolio encompasses drugs targeting diverse medical conditions, personalized cannabinoid formulations, and CBD-infused skincare along with food supplements. Established in 2019, the company, formerly known as Cannabotech LTD, is headquartered in Rishon LeZion, Israel.
Share Price
$0.24869863
Last synced: 2026-08-12
Market Cap
$1.02K
Change (1 day)
6.37%
Change (1 year)
-
Country
IL
Trade PsyRX CNS Bio-Tech Ltd (PSRX)

Category

P/B ratio for PsyRX CNS Bio-Tech Ltd (PSRX)
P/B ratio as of 2026 TTM: 0
According to PsyRX CNS Bio-Tech Ltd latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for PsyRX CNS Bio-Tech Ltd from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors